冠心病:左主干病变血运重建策略
上QQ阅读APP看书,第一时间看更新

参考文献

1.Cameron A,Kemp HG Jr,Fisher LD,et al.Left main coronary artery stenosis: angiographic determination.Circulation,1983,68: 484-489.
2.Fisher LD,Judkins MP,Lesperance J,et al.Reproducibility of coronary arteriographic reading in the coronary artery surgery study( CASS).Cathet Cardiovasc Diagn,1982,8: 565-575.
3.Lindstaedt M,Spiecker M,Perings C,et al.How good are experienced interventional cardiologists at predicting the functional significance of intermediate or equivocal left main coronary artery stenoses? Int J Cardiol,2007,20: 254-261.
4.Wu X,Chen Y,Liu H,et al.Comparison of long-term( 4-year) outcomes of patients with unprotected left main coronary artery narrowing treated with drug-eluting stents versus coronary-artery bypass grafting.Am J Cardiol,2010,105: 1728-1734.
5.包哈申,吕昀,柳景华,等.无保护左主干末端病变接受经皮冠状动脉介入治疗或冠状动脉旁路移植术远期效果评价.中国介入心脏病学杂志,2011,19: 186-190.
6.Roy P,Steinberg DH,Sushinsky SJ,et al.The potential clinical utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug-eluting stents.Eur Heart J,2008,29: 1851-1857.
7.吕树铮,李永斌.药物洗脱支架治疗左主干病变的疗效评价.心血管病学进展,2007,28: 162-164.
8.De Jaegere P,Mudra H,Figulla H,et al.Intravascular ultrasound-guided optimized stent deployment.Immediate and 6 months clinical and angiographic results from the multicenter ultrasound stenting in coronaries study( music study).Eur Heart J,1998,19: 1214-1223.
9.Bin Que,Yu-Tong Cheng,Hai Gao,et al.A successful team treatment for left main shock syndrome.Journal of Geriatric Cardiology,2013,10: 302-304.
10.柳景华,吕树铮.冠心病:解剖、功能及影像学.北京:中国协和医科大学出版社,2013.
11.Hausmann D,Erbel R,Alibelli-Chemarin MJ,et al.The safety of intracoronary ultrasound.A multicenter survey of 2207 examinations.Circulation,1995,91: 623-630.
12.Batkoff BW,Linker DT.Safety of intracoronary ultrasound: Data from a multicenter european registry.Cathet Cardiovasc Diagn,1996,38: 238-241.
13.Gorge G,Peters R,Pinto F,et al.Intravascular ultrasound: Safety and indications for use in 7085 consecutive patients studied in 32 centers in europe and israel.J Am Coll Cardiol,1996,27: 155A( abstract).
14.Mintz GS,Nissen SE,Anderson WD,et al.American college of cardiology clinical expert consensus document on standards for acquisition,measurement and reporting of Intravascular ultrasound studies( IVUS).A report of the american college of cardiology task force on clinical expert consensus documents.J Am Coll Cardiol,2001,37: 1478-1492.
15.Fassa AA,Wagatsuma K,Higano ST,et al.Intravascular ultrasoundguided treatment for angiographically indeterminate left main coronary artery disease: A long-term follow-up study.J Am Coll Cardiol,2005,45: 204-211.
16.Jasti V,Ivan E,Yalamanchili V,et al.Correlations between fractional flow reserve and intravascular ultrasound in patients with an ambiguous left main coronary artery stenosis.Circulation,2004,110: 2831-2836.
17.de la Torre Hernandez JM,Hernandez Hernandez F,Alfonso F,et al.Prospective application of pre-defined intravascular ultrasound criteria for assessment of intermediate left main coronary artery lesions results from the multicenter LITRO study.J Am Coll Cardiol,2011,58: 351-358.
18.Kang SJ,Lee JY,Ahn JM,et al.intravascular ultrasound-derived predictors for fractional flow reserve in intermediate left main disease.JACC Cardiovasc Interv,2011,4: 1168-1174.
19.Mintz GS,Pichard AD,Kovach JA,et al.Impact of preintervention iintravascular ultrasound imaging on transcatheter treatment strategies in coronary artery disease.Am J Cardiol,1994,73: 423-430.
20.Fitzgerald PJ,Ports TA,Yock PG.Contribution of localized calcium deposits to dissection after angioplasty.An observational study using intravascular ultrasound.Circulation,1992,86: 64-70.
21.Honye J,Mahon DJ,Jain A,et al.Morphological effects of coronary balloon angioplasty in vivo assessed by iintravascular ultrasound imaging.Circulation,1992,85: 1012-1025.
22.Stone GW,Hodgson JM,St Goar FG,et al.Improved procedural results of coronary angioplasty with intravascular ultrasound-guided balloon sizing: The clout pilot trial.Clinical outcomes with ultrasound trial ( clout) investigators.Circulation,1997,95: 2044-2052.
23.Pregowski J,Tyczynski P,Mintz GS,et al.Incidence and clinical correlates of ruptured plaques in saphenous vein grafts: An intravascular ultrasound study.J Am Coll Cardiol,2005,45: 1974-1979.
24.Pregowski J,Tyczynski P,Mintz GS,et al.Comparison of ruptured plaques in native coronary arteries and in saphenous vein grafts: An intravascular ultrasound study.Am J Cardiol,2006,97: 593-597.
25.Rioufol G,Gilard M,Finet G,et al.Evolution of spontaneous atherosclerotic plaque rupture with medical therapy: Long-term follow-up with intravascular ultrasound.Circulation,2004,110: 2875-2880.
26.Lockwood GR,Ryan LK,Hunt JW,et al.Measurement of the ultrasonic properties of vascular tissues and blood from 35-65 mHz.Ultrasound Med Biol,1991,17: 653-666.
27.Pasterkamp G,Borst C,Gussenhoven EJ,et al.Remodeling of de novo atherosclerotic lesions in femoral arteries: Impact on mechanism of balloon angioplasty.J Am Coll Cardiol 1995,26: 422-428.
28.Kimura T,Kaburagi S,Tamura T,et al.Remodeling of human coronary arteries undergoing coronary angioplasty or atherectomy.Circulation,1997,96: 475-483.
29.Baptista J,Umans VA,di Mario C,et al.Mechanisms of luminal enlargement and quantification of vessel wall trauma following balloon coronary angioplasty and directional atherectomy.Eur Heart J,1995,16: 1603-1612.
30.Moussa I,Moses J,Di Mario C,et al.Stenting after optimal lesion debulking( sold) registry.Angiographic and clinical outcome.Circulation,1998,98: 1604-1609.
31.Colombo A,Hall P,Nakamura S,et al.Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance.Circulation,1995,91: 1676-1688.
32.Kuntz RE,Baim DS,Safian RD.Pursuit of large lumen dimensions after coronary intervention( editorial).J Interv Cardiol,1993,6: 287-291.
33.黄方炯,叶穗晖,杨禁非,等.225例左主干狭窄冠状动脉旁路移植术.中华胸心血管外科杂志,2014,1: 27-29.
34.Russo RJ,Silva PD,Teirstein PS,et al.A randomized controlled trial of angiography versus intravascular ultrasound-directed bare-metal coronary stent placement( the avid trial).Circ Cardiovasc Interv,2009,2: 113-123.
35.Fitzgerald PJ,Oshima A,Hayase M,et al.Final results of the can routine ultrasound influence stent expansion ( cruise) study.Circulation,2000,102: 523-530.
36.Mudra H,di Mario C,de Jaegere P,et al.Randomized comparison of coronary stent implantation under ultrasound or angiographic guidance to reduce stent restenosis ( opticus study).Circulation,2001,104: 1343-1349.
37.Oemrawsingh PV,Mintz GS,Schalij MJ,et al.Intravascular ultrasound guidance improves angiographic and clinical outcome of stent implantation for long coronary artery stenoses: Final results of a randomized comparison with angiographic guidance( tulip study).Circulation,2003,107: 62-67.
38.Park SJ,Kim YH,Park DW,et al.Impact of intravascular ultrasound guidance on long-term mortality in stenting for unprotected left main coronary artery stenosis.Circ Cardiovasc Interv,2009,2: 167-177.
39.Sousa JE,Costa MA,Abizaid A,et al.Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: A quantitative coronary angiography and three-dimensional intravascular ultrasound study.Circulation,2001,103: 192-195.
40.Morice MC,Serruys PW,Sousa JE,et al.A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization.N Engl J Med,2002,346: 1773-1780.
41.Cheneau E,Leborgne L,Mintz GS,et al.Predictors of subacute stent thrombosis: Results of a systematic intravascular ultrasound study.Circulation,2003,108: 43-47.
42.Fujii K,Carlier SG,Mintz GS,et al.Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: An intravascular ultrasound study.J Am Coll Cardiol,2005,45: 995-998.
43.Cook S,Ladich E,Nakazawa G,et al.Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis.Circulation,2009,120: 391-399.
44.Sonoda S,Morino Y,Ako J,et al.Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation: Serial intravascular ultrasound analysis from the sirius trial.J Am Coll Cardiol,2004,43: 1959-1963.
45.Hong MK,Mintz GS,Lee CW,et al.Intravascular ultrasound predictors of angiographic restenosis after sirolimuseluting stent implantation.Eur Heart J,2006,27: 1305-1310.
46.Castagna MT,Mintz GS,Leiboff BO,et al.The contribution of“Mechanical”Problems to in-stent restenosis: An intravascular ultrasonographic analysis of 1090 consecutive in-stent restenosis lesions.Am Heart J,2001,142: 970-974.
47.Shaikh F,Maddikunta R,Djelmami-Hani M,et al.Stent fracture,an incidental finding or a significant marker of clinical in-stent restenosis? Catheter Cardiovasc Interv,2008,71: 614-618.
48.Costa MA,Sabate M,Angiolillo DJ,et al.Intravascular ultrasound characterization of the“Black hole”Phenomenon after drugeluting stent implantation.Am J Cardiol,2006,97: 203-206.
49.Mintz GS.Features and parameters of drug-eluting stent deployment discoverable by intravascular ultrasound.Am J Cardiol 2007,100: 26M-35M.
50.Escolar E,Mintz GS,Popma J,et al.Meta-analysis of angiographic versus intravascular ultrasound parameters of drug-eluting stent efficacy( from taxus iv,v,and vi).Am J Cardiol,2007,100: 621-626.
51.Jensen LO,Maeng M,Thayssen P,et al.Neointimal hyperplasia after sirolimus-eluting and paclitaxel-eluting stent implantation in diabetic patients: The randomized diabetes and drug-eluting stent( diabedes) intravascular ultrasound trial.Eur Heart J,2008,29: 2733-2741.
52.Miyazawa A,Ako J,Hongo Y,et al.Comparison of vascular response to zotarolimus-eluting stent versus sirolimuseluting stent: Intravascular ultrasound results from endeavorⅢ.Am Heart J 2008,155: 108-113.
53.Finn AV,Nakazawa G,Joner M,et al.Vascular responses to drug eluting stents: Importance of delayed healing.Arterioscler Thromb Vasc Biol,2007,27: 1500-1510.
54.Garcia-Garcia HM,Gonzalo N,Pawar R,et al.Assesment of the absorption process following bioabsorbable everolimus-eluting stent implantation: Temporal changes in strain values and tissue composition using intravascular ultrasound radiofrequency data analysis.A substudy of the absorb clinical trial.Eurointervention,2009: 443-448.
55.Park SJ,Hong MK,Lee CW,et al.Elective stenting of unprotected left main coronary artery stenosis: effect of debulking before stenting and intravascular ultrasound guidance.J Am Coll Cardiol 2001; 38: 1054-1060.
56.Erglis A,Narbute I,Kumsars I,et al.A randomized comparison of paclitaxel-eluting stents versus bare-metal stents for treatment of unprotected left main coronary artery stenosis.J Am Coll Cardiol 2007; 50: 491-497.
57.Tearney GJ,Brezinski ME,Boppart SA,et al.Images in cardiovascular medicine.Catheter-based optical imaging of a human coronary artery.Circulation,1996,94: 3013.
58.Tearney GJ,Jang IK,Kang DH,et al.Porcine coronary imaging in vivo by optical coherence tomography.Acta Cardiol,2000,55: 233-237.
59.Grube E,Gerckens U,Buellesfeld L,et al.Images in cardiovascular medicine.Intracoronary imaging with optical coherence tomography: a new high-resolution technology providing striking visualization in the coronary artery.Circulation,2002,106: 2409-2410.
60.Gonzalo N,Serruys PW,Regar E.Optical coherence tomography: clinical applications and the evaluation of DES.Minerva Cardioangiol,2008,56: 511-525.
61.Liu B,Brezinski ME.Theoretical and practical considerations on detection performance of time domain,Fourier domain,and swept source optical coherence tomography.J Biomed Opt,2007,12: 44007.
62.Low AF,Tearney GJ,Bouma BE,et al.Technology Insight: optical coherence tomography--current status and future development.Nat Clin Pract Cardiovasc Med,2006,3: 154-172.
63.Takarada S,Imanishi T,Liu Y,et al.Advantage of next-generation frequency-domain optical coherence tomography compared with conventional time-domain system in the assessment of coronary lesion.Catheter Cardiovasc Interv,2008,75: 202-206.
64.Gonzalo N TG,Serruys PW,van Soest G,et al.Second generation optical coherence tomography in clinical practice.High speed data acquisition shows excellent reproducibility in patients undergoing percutaneous coronary interventions.Rev Esp Cardiol,2010,In press.
65.Yun SH,Tearney GJ,Vakoc BJ,et al.Comprehensive volumetric optical microscopy in vivo.Nat Med,2006,12: 1429-433.
66.Yamaguchi T,Terashima M,Akasaka T,et al.Safety and feasibility of an intravascular optical coherence tomography image wire system in the clinical setting.Am J Cardiol,2008,101: 562-567.
67.Barlis P,Gonzalo N,Di Mario C,et al.A multicentre evaluation of the safety of intracoronary optical coherence tomography.EuroIntervention,2009,5: 90-95.
68.Fujino Y,Attizzani GF,Bezerra HG,et al.Serial assessment of vessel interactions after drug-eluting stent implantation in unprotected distal left main coronary artery disease using frequency-domain optical coherence tomography.JACC Cardiovasc Interv.2013,6: 1035-1045.
69.Kume T,Akasaka T,Kawamoto T,et al.Assessment of coronary intima—media thickness by optical coherence tomography: comparison with intravascular ultrasound.Circ J,2005,69: 903-7.
70.Zimarino M,Prati F,Stabile E,et al.Optical coherence tomography accurately identifies intermediate atherosclerotic lesions--an in vivo evaluation in the rabbit carotid artery.Atherosclerosis,2007,193: 94-101.
71.Kolodgie FD,Burke AP,Nakazawa G,et al.Is pathologic intimal thickening the key to understanding early plaque progression in human atherosclerotic disease? Arterioscler Thromb Vasc Biol,2007,27: 986-989.
72.Yabushita H,Bouma BE,Houser SL,et al.Characterization of human atherosclerosis by optical coherence tomography.Circulation,2002,106: 1640-1645.
73.Kume T,Akasaka T,Kawamoto T,et al.Assessment of coronary arterial plaque by optical coherence tomography.Am J Cardiol,2006,97: 1172-1175.
74.Rieber J,Meissner O,Babaryka G,et al.Diagnostic accuracy of optical coherence tomography and intravascular ultrasound for the detection and characterization of atherosclerotic plaque composition in ex-vivo coronary specimens: a comparison with histology.Coron Artery Dis,2006,17: 425-430.
75.Jang IK,Bouma BE,Kang DH,et al.Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound.J Am Coll Cardiol,2002,39: 604-609.
76.Kawasaki M,Bouma BE,Bressner J,et al.Diagnostic accuracy of optical coherence tomography and integrated backscatter intravascular ultrasound images for tissue characterization of human coronary plaques.J Am Coll Cardiol,2006,48: 81-88.
77.Low AF KY,Yiong-Huak C,Tearney GJ,et al.In vivo characterisation of coronary plaques with conventional grey-scale intravascular ultrasound: correlation with optical coherence tomography.EuroIntervention,2006,4: 626-632.
78.Manfrini O,Mont E,Leone O,et al.Sources of error and interpretation of plaque morphology by optical coherence tomography.Am J Cardiol,2006,98: 156-159.
79.van der Meer FJ,Faber DJ,Perree J,et al.Quantitative optical coherence tomography of arterial wall components.Lasers Med Sci,2005,20: 45-51.
80.van der Meer FJ,Faber DJ,Baraznji Sassoon DM,et al.Localized measurement of optical attenuation coefficients of atherosclerotic plaque constituents by quantitative optical coherence tomography.IEEE Trans Med Imaging,2005,24: 1369-1376.
81.Xu C,Schmitt JM,Carlier SG,et al.Characterization of atherosclerosis plaques by measuring both backscattering and attenuation coefficients in optical coherence tomography.J Biomed Opt,2008,13: 34003.
82.van Soest G,Goderie TP,Gonzalo N,et al.Imaging atherosclerotic plaque composition with intracoronary optical coherence tomography.Neth Heart J,2009,17: 448-450.
83.van Soest GGT,Regar E,KoljenoviS,et al.Atherosclerotic tissue characterization in vivo by intracoronary optical coherence tomography attenuation imaging.Journal of Biomedical Optics,2010,15: 011105.
84.Tearney GJ,Waxman S,Shishkov M,et al.Three-dimensional coronary artery microscopy by intracoronary optical frequency domain imaging.JACC Cardiovasc Imaging,2008,1: 752-761.
85.Gonzalo N,Serruys PW,Okamura T,et al.Optical coherence tomography assessment of the acute effects of stent implantation on the vessel wall: a systematic quantitative approach.Heart,2009,95: 1913-1919.
86.Bae JH,Kwon TG,Hyun DW,et al.Predictors of slow flow during primary percutaneous coronary intervention: an intravascular ultrasound-virtual histology study.Heart,2008,94: 1559-1564.
87.Hong YJ,Jeong MH,Choi YH,et al.Predictors of no-reflow after percutaneous coronary intervention for culprit lesion with plaque rupture in infarct-related artery in patients with acute myocardial infarction.J Cardiol,2009,54: 36-44.
88.Ohshima K,Ikeda S,Watanabe K,et al.Relationship between plaque composition and no-reflow phenomenon following primary angioplasty in patients with ST-segment elevation myocardial infarction-Analysis with virtual histology intravascular ultrasound.J Cardiol,2009,54: 205-213.
89.Tanaka A,Imanishi T,Kitabata H,et al.Lipid-rich plaque and myocardial perfusion after successful stenting in patients with non-STsegment elevation acute coronary syndrome: an optical coherence tomography study.Eur Heart J,2009,30: 1348-1355.
90.Tanimoto T,Imanishi T,Tanaka A,et al.Various types of plaque disruption in culprit coronary artery visualized by optical coherence tomography in a patient with unstable angina.Circ J,2009,73: 187-189.
91.Barlis P,Serruys PW,Devries A,et al.Optical coherence tomography assessment of vulnerable plaque rupture: Predilection for the plaque‘shoulder’.Eur Heart J,2008,16: 2023.
92.Kubo T,Imanishi T,Takarada S,et al.Assessment of culprit lesion morphology in acute myocardial infarction: ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy.J Am Coll Cardiol,2007,50: 933-939.
93.Tanaka A,Imanishi T,Kitabata H,et al.Morphology of exertion-triggered plaque rupture in patients with acute coronary syndrome: an optical coherence tomography study.Circulation,2008,118: 2368-2373.
94.Virmani R,Burke AP,Farb A,et al.Pathology of the vulnerable plaque.J Am Coll Cardiol 2006; 47: C13-18.
95.Ramcharitar S,Gonzalo N,van Geuns RJ,et al.First case of stenting of a vulnerable plaque in the SECRITT I trial-the dawn of a new era? Nat Rev Cardiol,2009,6: 374-378.
96.Garcia-Garcia HM,Gonzalo N,Granada JF,et al.Diagnosis and treatment of coronary vulnerable plaques.Expert Rev Cardiovasc Ther,2008,6: 209-222.
97.Kume T,Akasaka T,Kawamoto T,et al.Measurement of the thickness of the fibrous cap by optical coherence tomography.Am Heart J,2006,152: 755 e1-4.
98.Cilingiroglu M,Oh JH,Sugunan B,et al.Detection of vulnerable plaque in a murine model of atherosclerosis with optical coherence tomography.Catheter Cardiovasc Interv,2006,67: 915-923.
99.Barlis P.Serruys PW,Gonzalo N,et al.Assessment of Culprit and Remote Coronary Narrowings Using Optical Coherence Tomography with Long-Term Outcomes.Am J Cardiol,2008,102: 391-395.
100.Kubo T IT,Takarada S,Kuroi A,et al.Implication of Plaque Color Classification for Assessing Plaque Vulnerability.J Am Coll Cardiol,2008,1: 74-80.
101.Takano M,Jang IK,Inami S,et al.In vivo comparison of optical coherence tomography and angioscopy for the evaluation of coronary plaque characteristics.J Am Coll Cardiol,2008,101: 471-476.
102.Soeda T,Uemura S,Morikawa Y,et al.Diagnostic accuracy of dual-source computed tomography in the characterization of coronary atherosclerotic plaques: Comparison with intravascular optical coherence tomography.Int J Cardiol,2009,148: 313-318.
103.Chia S,Raffel OC,Takano M,et al.Association of statin therapy with reduced coronary plaque rupture: an optical coherence tomography study.Coron Artery Dis,2008,19: 237-242.
104.Takarada S,Imanishi T,Kubo T,et al.Effect of statin therapy on coronary fibrous-cap thickness in patients with acute coronary syndrome: Assessment by optical coherence tomography study.Atherosclerosis,2009,202: 491-497.
105.Nadkarni SK,Pierce MC,Park BH,et al.Measurement of collagen and smooth muscle cell content in atherosclerotic plaques using polarization-sensitive optical coherence tomography.J Am Coll Cardiol,2007,49: 1474-1481.
106.Tearney GJ,Yabushita H,Houser SL,et al.Quantification of macrophage content in atherosclerotic plaques by optical coherence tomography.Circulation,2003,107: 113-119.
107.MacNeill BD,Jang IK,Bouma BE,et al.Focal and multi-focal plaque macrophage distributions in patients with acute and stable presentations of coronary artery disease.J Am Coll Cardiol,2004,44: 972-979.
108.Raffel OC,Tearney GJ,Gauthier DD,et al.Relationship between a systemic inflammatory marker,plaque inflammation,and plaque characteristics determined by intravascular optical coherence tomography.Arterioscler Thromb Vasc Biol,2007,27: 1820-1827.
109.Garg SSP,van der Ent M,Schultz C,et al.First use in patients of a combined near infra-red spectroscopy and intra-vascular ultrasound catheter to identify composition and structure of coronary plaque.EuroIntervention,2010,5: 755-756.
110.Nakamura M,Nishikawa H,Mukai S,et al.Impact of coronary artery remodeling on clinical presentation of coronary artery disease: an intravascular ultrasound study.J Am Coll Cardiol,2001,37: 63-69.
111.Schoenhagen P,Ziada KM,Kapadia SR,et al.Extent and direction of arterial remodeling in stable versus unstable coronary syndromes: an intravascular ultrasound study.Circulation,2000,101: 598-603.
112.Kaji S,Akasaka T,Hozumi T,et al.Compensatory enlargement of the coronary artery in acute myocardial infarction.Am J Cardiol,2000,85: 1139-1141.
113.Burke AP,Kolodgie FD,Farb A,et al.Morphological predictors of arterial remodeling in coronary atherosclerosis.Circulation,2002,105: 297-303.
114.Fujii K,Carlier SG,Mintz GS,et al.Association of plaque characterization by intravascular ultrasound virtual histology and arterial remodeling.Am J Cardiol,2005,96: 1476-1483.
115.Kume T,Okura H,Kawamoto T,et al.Relationship between coronary remodeling and plaque characterization in patients without clinical evidence of coronary artery disease.Atherosclerosis,2008,197: 799-805.
116.Raffel OC,Merchant FM,Tearney GJ,et al.In vivo association between positive coronary artery remodelling and coronary plaque characteristics assessed by intravascular optical coherence tomography.Eur Heart J,2008,29: 1721-1728.
117.Li QX,Fu QQ,Shi SW,et al.Relationship between plasma inflammatory markers and plaque fibrous cap thickness determined by intravascular optical coherence tomography.Heart,96: 196-201.
118.Fujii K,Masutani M,Okumura T,et al.Frequency and predictor of coronary thin-cap fibroatheroma in patients with acute myocardial infarction and stable angina pectoris a 3-vessel optical coherence tomography study.J Am Coll Cardiol,2008,52: 787-788.
119.Sawada T,Shite J,Shinke T,et al.Low plasma adiponectin levels are associated with presence of thincap fibroatheroma in men with stable coronary artery disease.Int J Cardiol,2010,142: 250-256.
120.Gonzalo N,Serruys PW,Garcia-Garcia HM,et al.Quantitative ex vivo and in vivo comparison of lumen dimensions measured by optical coherence tomography and intravascular ultrasound in human coronary arteries.Rev Esp Cardiol,2009,62: 615-624.
121.Patwari P,Weissman NJ,Boppart SA,et al.Assessment of coronary plaque with optical coherence tomography and high-frequency ultrasound.Am J Cardiol,2000,85: 641-644.
122.Rentrop KP.Thrombi in acute coronary syndromes: revisited and revised.Circulation,2000,101: 1619-1626.
123.Meng L,Lv B,Zhang S,Yv B.et al.In vivo optical coherence tomography of experimental thrombosis in a rabbit carotid model.Heart,2008,94: 777-780.
124.Okamura TSP,Regar E.Three dimensional visualization of intracoronary thrombus during stent implantation using the second generation,Fourier Domain optical coherence tomography.Eur Heart J,2010,31: 625.
125.Kume T,Okura H,Kawamoto T,et al.Images in cardiovascular medicine.Fibrin clot visualized by optical coherence tomography.Circulation,2008,118: 426-427.
126.Prati F1,Guagliumi G,Mintz GS,et al.Expert review document part 2: methodology,terminology and clinical applications of optical coherence tomography for the assessment of interventional procedures.Am J Cardiol.2008,102: 391-395.
127.Alcock R,Yong AS,Yiannikas J,et al.Optical coherence tomography-guided left main stem stenting: a new approach? Tex Heart Inst J.2012; 39( 4) : 596-597.
128.张维东,马长生,吴学思,等.大动脉炎累及冠状动脉左主干致严重狭窄一例.中华心血管病杂志,2003,03: 46.
129.LIU Tong,LU Jia-kai,GAN Hui-li,et al.High volume practice proved the safety of off-pump coronaryartery bypass surgery in left main coronary artery lesions: a two-year single center experience.Chinese Medical Journal,2012,125( 21) : 3861-3867.
130.Thomas AC,Davies MJ,Dilly S,et al.Potential errors in the estimation of coronary arterial stenosis from clinical arteriography with reference to the shape of the coronary arterial lumen.Br Heart J,1968,55: 129-139.
131.Katritsis D,Webb-Peploe M.Limitations of coronary angiography: an underestimated problem? Clin Cardiol,1991,14: 20-24.
132.Dvir D,Marom H,Guetta V,Kornowski R.Three-dimensional coronary reconstruction from routine single-plane coronary angiograms: in vivo quantitative validation.Int J Cardiovasc Intervent,2005,7: 141-145.
133.Xiao Yanyan,Jin Mei,Han Ling,et al.Two congenital coronary abnormalities affecting heart function: anomalous origin of the left coronary artery from the pulmonary artery and congenital left main coronary artery atresia.Chinese Medical Journal,2014,127( 21) : 3724-3731.
134.Schlundt C,Kreft JG,Fuchs F,et al.Three dimensional on line reconstruction of coronary bifurcated lesions to optimize side-branch stenting.Catheter Cardiovasc Interv,2006,68: 249-253.
135.Gradaus R,Mathies K,Breithardt G,et al.Clinical assessment of a new real time 3 D quantitative coronary angiography system: evaluation in stented vessel segments.Catheter Cardiovasc Interv,2006,68: 44-49.
136.Wu X,Chen Y,Kubo T,et al.Long-term( 4-year) outcomes and predictors of adverse cardiac events after sirolimus-eluting stent implantation in unprotected left main coronary artery.Int Heart J 2010,51( 6) : 377-382.
137.Edmundo Patricio Lopes Lao,Shao-Ping Nie,Chang-Sheng Ma.Immediate bail-out TAP-stenting for the treatment of iatrogenicaortocoronary dissection involving left main bifurcation.Journal of Geriatric Cardiology,2013,10: 202-204.
138.Ramcharitar S,Daeman J,Patterson M,et al.First direct in vivo comparison of two commercially available three-dimensional quantitative coronary angiography systems.Catheter Cardiovasc Interv,2008,71: 44-50.
139.Tu S,Koning G,Jukema W,et al.Assessment of obstruction length and optimal viewing angle from biplane X-ray angiograms.Int J Cardiovasc Imaging,2010,26: 5-17.
140.Gollapudi R.R,Valencia R,Lee S.S,et al.Utility of three-dimensional reconstruction of coronary angiography to guide percutaneous coronary intervention.Catheter Cardiovasc Interv,2007,69: 479-482.
141.Garcia J.A,Movassaghi B,Casserly I.P,et al.Determination of optimal viewing regions for X-ray coronary angiography based on a quantitative analysis of 3D reconstructed models.Int J Cardiovasc Imaging,2009,25: 455-462.
142.Green N.E,Chen S.Y,Hansgen A.R,et al.Angiographic views used for percutaneous coronary interventions: a three-dimensional analysis of physician-determined vs.computer-generated views.Catheter Cardiovasc Interv,2005,64: 451-459.
143.Wellnhofer E,Wahle A,Mugaragu I,et al.Validation of an accurate method for three-dimensional reconstruction and quantitative assessment of volumes,lengths and diameters of coronary vascular branches and segments from biplane angiographic projections.Int J Card Imaging,1999,15: 339-353.
144.Messenger J.C,Chen S.Y,Carroll J.D,et al.3D coronary reconstruction from routine singleplane coronary angiograms: clinical validation and quantitative analysis of the right coronary artery in 100 patients.Int J Card Imaging,2000,16: 413-427.
145.Gan HL,Zhang JQ,Xiao W,et al.Ostial left main coronary artery stenosis as an additional risk factor inoffpump coronary artery bypass grafting.J Thorac Cardiovasc Surg 2012 Jan,143( 1) : 103-110.
146.Rui Tian,Hongtao Xu,and Shuzheng Lv.The Use of a Modified EuroSCORE toEvaluate Mortality Risk in PercutaneousCoronary Intervention.Ann Thorac Cardiovasc Surg,2014,20: 32-37.
147.Schuurbiers J.C,Lopez N.G,Ligthart J,et al.In vivo validation of CAAS QCA-3D coronary reconstruction using fusion of angiography and intravascular ultrasound( ANGUS).Catheter Cardiovasc Interv,2009,73: 620-626.
148.Bruining N,Tanimoto S,Otsuka M,et al.Quantitative multi-modality imaging analysis of a bioabsorbable poly-L-lactic acid stent design in the acute phase: a comparison between 2-and 3D-QCA,QCU and QMSCT-CA.EuroIntervention,2008,4: 285-291.
149.Tsuchida K,van der Giessen W.J,et al.In vivo validation of a novel threedimensional quantitative coronary angiography system( CardiOp-B) : comparison with a conventional two-dimensional system( CAASⅡ) and with special reference to optical coherence tomography.EuroIntervention,2007,3: 100-108.
150.Girasis C,Serruys P.W,Onuma Y,et al.3-Dimensional Bifurcation Angle Analysis in Patients With Left Main Disease A Substudy of the SYNTAX Trial( SYNergy Between Percutaneous Coronary Intervention With TAXus and Cardiac Surgery).JACC Cardiovasc Interv,2010,3: 41-48.
151.Hui-Li Gan,Jian-Qun,Zhang,Ping Bo,et al.Statins Decrease Adverse Outcomes in Coronary Artery Bypassfor Extensive Coronary Artery Disease as well as Left MainCoronary Stenosis.Cardiovascular Therapeutics,2010,28: 70-79.
152.Abdulla J,Abildstrom SZ,Gotzsche O,et al.64-multislice detector computed tomography coronary angiography as potential alternative to conventional coronary angiography: a systematic review and meta-analysis.Eur Heart J,2007,28: 3042-3050.
153.Hausleiter J,Meyer T,Hermann F,et al.Estimated radiation dose associated with cardiac CT angiography.JAMA,2009,301: 500-507.
154.Budoff MJ,Dowe D,Jollis JG,et al.Diagnostic performance of 64-multidetector row coronary computer tomographic angiography for evaluation of coronary artery stenosis in individuals without known coronary artery disease: results from the prospective multicenter ACCURACY( Assessment by Coronary Computed Tomographic Angiography of Individuals Undergoing Invasive Coronary Angiography) trial.J Am Coll Cardiol,2008,52: 1724-1732.
155.Mollet NR,Cademartiri F,van Mieghem CA,et al.High-resolution spiral computed tomography coronary angiography in patients referred for diagnostic conventional coronary angiography.Circulation,2005,112: 2318-2323.
156.Leber AW,Knez A,von Ziegler F et al.Quantification of obstructive and nonobstructive coronary lesions by 64-slice computed tomography: a comparative study with quantitative coronary angiography and intravascular ultrasound.J Am Coll Cardiol,2005,46: 147-154.
157.Rodriguez-Granillo GA,Rosales MA,Degrossi E,et al.Multislice CT coronary angiography for the detection of burden,morphology and distribution of atherosclerotic plaques in the left main bifurcation.Int J Cardiovasc Imaging,2007,23: 389-392.
158.Van Mieghem CA,Cademartiri F,Mollet NR,et al.Multislice spiral computed tomography for the evaluation of stent patency after left main coronary artery stenting: a comparison with conventional coronary angiography and intravascular ultrasound.Circulation,2006,114: 645-653.
159.Cordeiro MA,Lima JA.Atherosclerotic plaque characterization by multidetector row computed tomography angiography.J Am Coll Cardiol,2006,47( Suppl 8) : C40-47.
160.Wilensky RL,Song HK,Ferrari VA.Role of magnetic resonance and intravascular magnetic resonance in the detection of vulnerable plaques.J Am Coll Cardiol,2006,47: C48-56.
161.Kim WY,Danias PG,Stuber M,et al.Coronary magnetic resonance angiography for the detection of coronary stenoses.N Engl J Med,2001,345: 1863-1869.
162.Sakuma H,Ichikawa Y,Chino S,et al.Detection of coronary artery stenosis with whole-heart coronary magnetic resonance angiography.J Am Coll Cardiol,2006,48: 1946-1950.
163.White CW,Wright CB,Doty DB,et al.Does visual interpretation of the coronary arteriogram predict physiologic importance of a coronary stenosis? N Engl J Med,1984,310: 819-824.
164.Klocke FJ.Measurements of coronary blood flow and degree of stenosis; current clinical implications and continuing uncertainties.J Am Coll Cardiol,1983,1: 131-141.
165.Kern MJ,Samady H.Current concepts of integrated coronary physiology in the catheterization laboratory.J Am Coll Cardiol,2010,55: 173-185.
166.Pijls NHJ,van Gelder B,van der Voort P,et al.Fractional flow reserve.A useful index to evaluate the influence of an epicardial coronary stenosis on myocardial blood flow.Circulation,1995,92: 3183-3193.
167.Tonino PA,De Bruyne B,Pijls NH,et al.FAME Study Investigators.Fractional flow reserve versus angiography for guiding percutaneous coronary intervention.N Engl J Med,2009,360: 213-224.
168.Serruys PW,Morice MC,Kappetein AP,et al.SYNTAX Investigators.Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.N Engl J Med,2009,360: 961-972.
169.Gould K.Coronary artery stenosis and reversing atherosclerosis.Londres: Arnold Publishers,1999.3-29.
170.Opie LH.The Heart: physiology,from cell to circulation.Philadelphia: Lippincot-Raven,1998.267-294.
171.Marcus ML.Metabolic regulation of coronary blood flow.En: Marcus ML,editor.The coronary circulation in health and disease.New York: McGraw-Hill,1983.65-92.
172.Hoffman J.,Spaan J.A.E.Pressure-flow relations in coronary circulation.Physiol Rev 1990; 70: 331-390.
173.Mancini GBJ,McGillem MJ,DeBoe SF,et al.The diastolic hyperemic flow vs.pressure relation: a new index of coronary stenosis severity and flow reserve.Circulation,1989,80: 9419-9450.
174.Gould KL,Lipscomb K,Hamilton GW.Physiological basis for assessing critical coronary stenosis: instantaneous flow response and regional redistribution during coronary hyperemia as measures of coronary flow reserve.Am J Cardiol,1974,33: 87-94.
175.Kirkeeide RL,Gould KL,Parsel L.Assessment of coronary stenosis by myocardial perfusion imaging during pharmacologic coronary vasodilatation.Ⅶ.Validation of coronary flow reserve as a single integrated functional measure of stenosis severity reflecting all its geometric dimensions.J Am Coll Cardiol,1986,7: 103-113.
176.Candell-Riera J,Martín-Comín J,Escaned J,et al.Physiologic evaluation of coronary circulation.Role of invasive and non invasive techniques.Rev Esp Cardiol,2002,55: 271-291.
177.Brown BG,Bolson EL,Dodge HT.Dynamic mechanisms in human coronary stenosis.Circulation,1984,70: 917-922.
178.L’Abatte A,Sambuceti G,HaunsS,et al.Methods for evaluating coronary microvasculature in humans.Eur Heart J,1999,200: 1300-1313.
179.Camici PG,Crea F.Coronary microvascular dysfunction.N Engl J Med,2007,356: 830-840.
180.Escaned J,Flores A,García-Pavía P,et al.Assessment of microcirculatory remodeling with intracoronary flow velocity and pressure measurements: validation with endomyocardial sampling in cardiac allografts.Circulation,2009,120: 1561-1568.
181.Escaned J,Colmenárez H,Ferrer MC,et al.Diastolic dysfunction in diabetic patients assessed with Doppler echocardiography: relationship with coronary atherosclerotic burden and microcirculatory impairment.Rev Esp Cardiol,2009,62: 1395-1403.
182.Marzilli M,Sambuceti G,Fedele S,et al.Coronary microcirculatory vasoconstriction during ischemia in patients with unstable angina.J Am Coll Cardio,l 2000,35: 327-334.
183.Eeckhout E,Kern MJ The coronary non-reflow phenomenon: a review of mechanisms and therapies.Eur Heart J,2001,22: 729-739.
184.Baumgart D,Haude M,Grge G,et al.Augmented alpha-adrenergic constriction of atherosclerotic human coronary arteries.Circulation,1999,99,2090-2097.
185.Meuwissen M,Chamuleau SAJ,Siebes M,et al.Role of variability in microvascular resistance on fractional flow reserve and coronary blood flow velocity reserve in intermediate coronary lesions.Circulation,2001,103: 184-187.
186.De Bruyne B,Bartunek J,Sys SU,et al.Simultaneous coronary pressure and flow velocity measurements in humans: feasibility,reproducibility,and hemodynamic dependence of coronary flow velocity reserve,hyperemic flow versus pressure slope index,and fractional flow reserve.Circulation,1996,94: 1842-1849.
187.Abe M.,Tomiyama H.,Yoshida H.,Doba N.Diastolic fractional flow reserve to assess the functional severity of moderate coronary stenoses.Comparison with fractional flow reserve and coronary flow velocity reserve.Circulation,2000,102: 2365-2370.
188.Escaned J,Flores A,Corts J,et al.Influence of flow characteristics of the right and left coronary arteries on fractional flow reserve measurements.Circulation,2000,102( SupplⅡ) : 639.
189.Escaned J,Corts J,Flores A,et al.Importance of diastolic fractional flow reserve and dobutamine challenge in physiologic assessment of myocardial bridging.J Am Coll Cardiol,2003,42: 226-233.
190.De Bruyne B,Pijls NH,Barbato E,et al.Intracoronary and intravenous adenosine 5’-triphosphate,adenosine,papaverine,and contrast medium to assess fractional flow reserve in humans.Circulation,2003,107: 1877-1883.
191.Casella G,Leibig M,Schiele TM,et al.Are high doses of intracoronary adenosine an alternative to standard intravenous adenosine for the assessment of fractional flow reserve? Am Heart J,2004,148: 590-595.
192.Murtagh B,Higano S,Lennon R,et al.Role of incremental doses of intracoronary adenosine for fractional flow reserve assessment.Am Heart J,2003,146: 99-105.
193.Bartunek J,Wijns W,Heyndrickx GR,et al.Effects of dobutamine on coronary stenosis physiology and morphology: comparison with intracoronary adenosine.Circulation,1999,100: 243-249.
194.Miller DD,Donouhue TJ,Younis LT,et al.Correlation of pharmacological 99mTcsestamibi myocardial perfusion imaging with poststenotic coronary flow reserve in patients with angiographically intermediate artery stenoses.Circulation,1994,89: 2150-2160.
195.Joye ID,Schulman DS,Lasorda D,et al.Intracoronary Doppler guidewire versus stress single photon emission computed tomographic thallium-201 imaging in assessment of intermediate coronary stenoses.J Am Coll Cardiol,1994,24: 940-947.
196.Califf RM,Armstrong PW,Carver JR,et al.27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events.Task Force 5.Stratification of patients into high,medium and low risk subgroups for purposes of risk factor management.J Am Coll Cardiol,1996,27: 1007-1019.
197.Bech GJ,Droste H,Pijls NH,et al.Value of fractional flow reserve in making decisions about bypass surgery for equivocal left main coronary artery disease.Heart,2001,86: 547-552.
198.Jimnez-Navarro M,Hernández-García JM,Alonso-Briales JH,et al.Should we treat patients with moderately severe stenosis of the left main coronary artery and negative FFR results? J Invasive Cardiol,2004,16: 398-400.
199.Lindstaedt M,Yazar A,Germing A,et al.Clinical outcome in patients with intermediate or equivocal left main coronary artery disease after deferral of surgical revascularization on the basis of fractional flow reserve measurements.Am Heart J,2006,152: e1-9.
200.Legutko J,Dudek D,Rzeszutko L,et al.Fractional flow reserve assessment to determine the indications for myocardial revascularisation in patients with borderline stenosis of the left main coronary artery.Kardiol Pol,2005,63: 499-506.
201.Suemaru S,Iwasaki K,Yamamoto K,et al.Coronary pressure measurement to determine treatment strategy for equivocal left main coronary artery lesions.Heart Vessels,2005,20: 271-277.
202.Courtis J,Rods-Cabau J,Larose E,et al.Usefulness of coronary fractional flow reserve measurements in guiding clinical decisions in intermediate or equivocal left main coronary stenoses.Am J Cardiol,2009,103: 943-949.
203.Hamilos M,Muller O,Cuisset T,et al.Long-term clinical outcome after fractional flow reserve-guided treatment in patients with angiographically equivocal left main coronary artery stenosis.Circulation,2009,120: 1505-1512.
204.Samady H,McDaniel M,Veledar E,et al.Baseline fractional flow reserve and stent diameter predict optimal post-stent fractional flow reserve and major adverse cardiac events after bare-metal stent deployment.JACC Cardiovasc Interv,2009,2: 357-363.
205.Pijls NH,Klauss V,Siebert U,et al.Fractional Flow Reserve( FFR) Post-Stent Registry Investigators.Coronary pressure measurement after stenting predicts adverse events at follow-up: a multicenter registry.Circulation,2002,105: 2950-2954.
206.Rieber J,Schiele TM,Erdin P,et al.Fractional flow reserve predicts major adverse cardiac events after coronary stent implantation.Z Kardiol,2002,9( Suppl 3) : 132-136.
207.Klauss V,Erdin P,Rieber J,et al.Fractional flow reserve for the prediction of cardiac events after coronary stent implantation: results of a multivariate analysis.Heart,2005,91: 203-206.
208.Koo BK,Waseda K,Kang HJ,et al.Anatomic and functional evaluation of bifurcation lesions undergoing percutaneous coronary intervention.Circ Cardiovasc Interv,2010,3: 113-119.
209.Koo BK,Park KW,Kang H.,et al.Physiological evaluation of the provisional side-branch intervention strategy for bifurcation lesions using fractional flow reserve.Eur Heart J,2008,29: 726-232.
210.Bellenger NG,Swallow R,Wald DS,et al.Haemodynamic significance of ostial side branch nipping following percutaneous intervention at bifurcations: a pressure wire pilot study.Heart,2007,93: 249-250.
211.Koo BK,Kang HJ,Youn TJ,et al.Physiologic assessment of jailed side branch lesions using fractional flow reserve.J Am Coll Cardiol,2005,46: 633-637.
212.Wongpraparut N,Yalamanchili V,Pasnoori V,et al.Thirty-month outcome after fractional flow reserve-guided versus conventional multivessel percutaneous coronary intervention.Am J Cardio,l 2005,96: 877-884.
213.Leesar MA,Abdul-Baki T,Akkus NI,et al.Use of fractional flow reserve versus stress perfusion scintigraphy after unstable angina.Effect on duration of hospitalization,cost,procedural characteristics,and clinical outcome.J Am Coll Cardiol,2003,41: 1115-1121.
214.Fearon WF,Yeung AC,Lee DP,et al.Costeffectiveness of measuring fractional flow reserve to guide coronary interventions.Am Heart J,2003,145: 882-887.
215.Fearon WF,Bornschein B,Gothe R,et al.Abstract 1063: Economic Evaluation of the Fractional Flow Reserve vs.Angiography for Multivessel Evaluation( FAME) Study.Circulation,2009,120: S437.
216.Kern MJ.Is the coronary physiology of bypass grafts different from that of the native coronary artery? Comment on the“Hemodynamic evaluation of coronary artery bypass graft lesions using fractional flow reserve”.Catheter Cardiovasc Interv,2008,72: 486-487.